INVENTIVA SA - ADR (IVA) Institutional Shareholders
INVENTIVA SA - ADR (IVA) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $319.10M in IVA holdings during the latest filing period.
Caligan Partners Lp is currently the largest disclosed institutional shareholder of IVA tracked by InsiderSet, reporting ownership valued at approximately $30.86M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $30.86M, representing an estimated loss of -0.00% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 48% of the total disclosed IVA value among the investors covered in this analysis. Major shareholders include Caligan Partners Lp, Samsara Biocapital, Llc, Paradigm Biocapital Advisors Lp, and several other long-term asset managers with concentrated positions in INVENTIVA SA - ADR (IVA).
This page ranks the largest institutional IVA shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
87
Total Reported Value
$319.10M
Largest Holder
Caligan Partners Lp
Largest Position
$30.86M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
103
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Caligan Partners Lp | 1.49% | 8,163,191 | $30,856,862 | $30,856,862 | -$0 | -0.00% | |
| Samsara Biocapital, Llc | 1.96% | 6,314,805 | $23,869,963 | $23,869,963 | -$0 | -0.00% | |
| Paradigm Biocapital Advisors Lp | 0.28% | 4,000,000 | $15,120,000 | $15,120,000 | $0 | 0.00% | |
| Andera Partners | 6.65% | 3,633,181 | $13,733,424 | $13,733,424 | +$0 | +0.00% | |
| Adar1 Capital Management, Llc | 0.64% | 3,606,656 | $13,633,160 | $13,633,160 | -$0 | -0.00% | |
| Millennium Management Llc | 0.01% | 3,512,174 | $13,276,018 | $13,276,018 | -$0 | -0.00% | |
| Symbiosis Capital Partners, Llc | 24.76% | 2,354,000 | $13,064,700 | $8,898,120 | -$4,166,580 | -31.89% | |
| Nantahala Capital Management, Llc | 0.61% | 2,686,393 | $10,154,566 | $10,154,566 | -$0 | -0.00% | |
| Trails Edge Capital Partners, Lp | 1.60% | 2,657,997 | $10,047,228 | $10,047,229 | +$1 | +0.00% | |
| Squadron Capital Management Llc | 3.15% | 2,435,000 | $9,204,300 | $9,204,300 | $0 | 0.00% | |
| Woodline Partners Lp | 0.03% | 2,323,149 | $8,781,503 | $8,781,503 | +$0 | +0.00% | |
| Aberdeen Group Plc | 0.01% | 2,307,773 | $8,723,382 | $8,723,382 | -$0 | -0.00% | |
| Ubs Group Ag | 0.00% | 2,305,192 | $8,713,626 | $8,713,626 | -$0 | -0.00% | |
| Boothbay Fund Management, Llc | 0.14% | 2,003,782 | $7,574,296 | $7,574,296 | -$0 | -0.00% | |
| Patient Square Capital Lp | 1.15% | 1,967,171 | $7,435,906 | $7,435,906 | +$0 | +0.00% | |
| Nextbio Capital Management Lp | 3.11% | 1,787,984 | $6,758,580 | $6,758,580 | -$0 | -0.00% | |
| Citadel Advisors Llc | 0.00% | 1,784,566 | $6,745,659 | $6,745,659 | +$0 | +0.00% | |
| Ameriprise Financial Inc | 0.00% | 1,697,148 | $6,415,219 | $6,415,219 | +$0 | +0.00% | |
| Point72 Asset Management, L.P. | 0.01% | 1,683,012 | $6,361,785 | $6,361,785 | +$0 | +0.00% | |
| Integral Health Asset Management, Llc | 0.24% | 1,520,000 | $5,745,600 | $5,745,600 | $0 | 0.00% | |
| Yu Fan | 5.25% | 1,500,000 | $5,670,000 | $5,670,000 | $0 | 0.00% | |
| Nea Management Company, Llc | 0.35% | 1,462,586 | $5,528,575 | $5,528,575 | +$0 | +0.00% | |
| Stempoint Capital Lp | 0.93% | 1,426,320 | $5,391,490 | $5,391,490 | -$0 | -0.00% | |
| Propel Bio Management, Llc | 2.53% | 1,281,212 | $4,842,981 | $4,842,981 | +$0 | +0.00% | |
| Kingdon Capital Management, L.L.C. | 0.65% | 1,270,000 | $4,800,600 | $4,800,600 | $0 | 0.00% | |
| Jpmorgan Chase & Co | 0.00% | 1,309,100 | $4,647,305 | $4,948,398 | +$301,093 | +6.48% | |
| Adage Capital Partners Gp, L.L.C. | 0.01% | 1,120,000 | $4,233,600 | $4,233,600 | $0 | 0.00% | |
| Ikarian Capital, Llc | 0.68% | 1,129,101 | $4,152,521 | $4,268,002 | +$115,481 | +2.78% | |
| Polar Capital Holdings Plc | 0.01% | 1,074,214 | $4,060,529 | $4,060,529 | -$0 | -0.00% | |
| Marshall Wace, Llp | 0.00% | 965,907 | $3,651,131 | $3,651,128 | -$3 | -0.00% | |
| Alyeska Investment Group, L.P. | 0.01% | 909,000 | $3,436,020 | $3,436,020 | $0 | 0.00% | |
| Morgan Stanley | 0.00% | 901,640 | $3,408,199 | $3,408,199 | +$0 | +0.00% | |
| Jane Street Group, Llc | 0.00% | 901,369 | $3,407,175 | $3,407,175 | -$0 | -0.00% | |
| Highvista Strategies Llc | 0.72% | 831,442 | $3,142,851 | $3,142,851 | -$0 | -0.00% | |
| Deep Track Capital, Lp | 0.04% | 800,000 | $3,024,000 | $3,024,000 | $0 | 0.00% | |
| Two Sigma Investments, Lp | 0.00% | 728,111 | $2,752,260 | $2,752,260 | -$0 | -0.00% | |
| Diadema Partners Lp | 0.96% | 740,786 | $2,725,718 | $2,800,171 | +$74,453 | +2.73% | |
| Bvf Inc/Il | 0.07% | 686,040 | $2,593,231 | $2,593,231 | +$0 | +0.00% | |
| Fmr Llc | 0.00% | 685,400 | $2,590,812 | $2,590,812 | $0 | 0.00% | |
| Ally Bridge Group (Ny) Llc | 3.09% | 634,800 | $2,399,544 | $2,399,544 | $0 | 0.00% | |
| Qube Research & Technologies Ltd | 0.00% | 397,558 | $1,502,769 | $1,502,769 | +$0 | +0.00% | |
| J. Goldman & Co Lp | 0.04% | 337,500 | $1,275,750 | $1,275,750 | $0 | 0.00% | |
| Simplify Asset Management Inc. | 0.02% | 313,483 | $1,184,966 | $1,184,966 | -$0 | -0.00% | |
| Artisan Partners Limited Partnership | 0.00% | 263,538 | $996,174 | $996,174 | -$0 | -0.00% | |
| Ghisallo Capital Management Llc | 0.02% | 250,000 | $945,000 | $945,000 | $0 | 0.00% | |
| Burkehill Global Management, Lp | 0.03% | 225,000 | $850,500 | $850,500 | $0 | 0.00% | |
| Seven Grand Managers, Llc | 0.03% | 225,000 | $850,500 | $850,500 | $0 | 0.00% | |
| Goldman Sachs Group Inc | 0.00% | 224,499 | $848,606 | $848,606 | +$0 | +0.00% | |
| Xtx Topco Ltd | 0.01% | 214,282 | $809,986 | $809,986 | -$0 | -0.00% | |
| Persistent Asset Partners Ltd | 0.25% | 209,182 | $790,708 | $790,708 | -$0 | -0.00% |
Frequently asked questions about IVA
Who owns the most IVA stock?
The largest holders of IVA are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for INVENTIVA SA - ADR (IVA).
Is IVA widely held by superinvestors?
Many widely followed stocks like IVA appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly IVA is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.